APOE and Alzheimer disease: In the context of targeting ApoE4 fragmentation as a therapeutical strategy in AD, the inhibition of specific proteases is proposed to be a promising approach; however, a more detailed study about the enzymes involved in neuronal ApoE4 cleavage is still necessary [11,21,45].